A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 38/26 (2006.01) A61K 48/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/567 (2006.01)
Patent
CA 2592065
The present invention relates to at least one novel human GLP-1 mimetibody or agonist, or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 mimetibody or agonist, or specified portion or variants, GLP-1 mimetibody or agonist, or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including diabetes related therapeutic and/or diagnostic compositions, methods and devices.
La présente invention concerne au moins un nouveau corps mimétique ou un agoniste GLP-1 humain ou, une partie spécifiée ou un variant de ce corps comprenant des acides nucléiques isolés codant pour au moins un corps mimétique, un agoniste GLP-1, une partie spécifiée ou des variants de ce corps, des vecteurs, des cellules hôtes, des animaux transgéniques, des plantes et des procédés de fabrication et d'utilisation de ceux-ci, y compris des compositions diagnostiques et/ou thérapeutiques relatives au diabète, des procédés et des dispositifs.
Lark Michael
O'neil John
O'neil Karyn T.
Picha Kristen
Xu Gang
Centocor Inc.
Centocor Ortho Biotech Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Glp-1 agonists, compositions, methods and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glp-1 agonists, compositions, methods and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glp-1 agonists, compositions, methods and uses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1868879